Kentucky sues major PBMs over rising insulin prices | Healthcare Dive
A string of states and cities have filed recent suits against PBMs and drug manufacturers alleging they work in tandem to raise the cost of insulin.| Healthcare Dive
A string of states and cities have filed recent suits against PBMs and drug manufacturers alleging they work in tandem to raise the cost of insulin.| Healthcare Dive
It’s the most recent action targeting PBMs for allegedly using their market power to raise drug prices, and comes as the Federal Trade Commission also launched a similar investigation.| Healthcare Dive
In 2022, the PBM market remained highly consolidated—although there were some intriguing share shifts among the largest players. | www.drugchannels.net
Pharmacy groups cheered the news, which reversed a vote earlier this year by FTC commissioners not to investigate PBMs' pricing and contractual practices.| Healthcare Dive
The PBM contract is one of the largest to change hands recently, one analyst said. Centene will drop CVS Caremark in 2024.| Healthcare Dive
